MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0066240
Gromaxformulations Private Limited
Gromaxformulations Private Limited - pharma in Sriperumbudur, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.12 Cr
▼ 31% YoY
Net loss · FY 2025
₹8.55 Lakh
Net margin -7.6%
EBITDA · FY 2025
-₹5.61 Lakh
EBITDA margin -5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.5 Lakh
Issued & subscribed
Open charges
₹54.55 Lakh
Satisfied ₹16 Lakh
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
About Gromaxformulations Private Limited
Data last updated:
Gromaxformulations Private Limited is a private limited company based in Sriperumbudur, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 July 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24304TN2019PTC130323. Its GSTIN is 33AAHCG8924F1ZL (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Murali Gurunathan and Perumal Premila.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Sriperumbudur, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.12 Cr, a decline of 31% compared to the previous year. For the same year it recorded a net loss of ₹8.55 Lakh (net margin -7.6%) and EBITDA of -₹5.61 Lakh (EBITDA margin -5%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹54.55 Lakh and satisfied charges of ₹16 Lakh on record.
Gromaxformulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0066240).
Company details
CIN U24304TN2019PTC130323
Registration Number 130323
Incorporation Date 04 July 2019
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TN-02-0066240
Recognitions & Rankings of Gromaxformulations
Contact details
Gromaxformulations Private Limited's registered office is in Sriperumbudur, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No. 6 – 1 Cholan Street, Jayalakshami Nagar Madananthapuram, Sriperumbudur, Tamil Nadu, India – 600125
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Gromaxformulations Private Limited, buy the company report.
Comprehensive company report
Gromaxformulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Gromaxformulations is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Gromaxformulations Private Limited, buy the company report.
Financials of Gromaxformulations Private Limited
FY 2025 filings availableGromaxformulations Private Limited reported revenue of ₹1.12 Cr (down 31% YoY) for FY 2025.
Revenue · FY 2025
₹1.12 Cr ▼ 31%
Net loss · FY 2025
₹8.55 Lakh margin -7.6%
EBITDA · FY 2025
-₹5.61 Lakh margin -5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 31%
3 years · compounded
▼ 11%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 163%
3 years · compounded
▼ 32%
5 years · compounded
▼ 41%
Revenue fell 31% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 163% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹5.61 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.55 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5% | ||||
| Net Profit Margin | -7.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gromaxformulations Private Limited, buy the company report.
Board of directors of Gromaxformulations Private Limited
Gromaxformulations has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Murali Gurunathan | Director | 04 Jul 2019 | 7 Years 3 Months | Current |
| Perumal Premila | Additional Director | 24 Apr 2024 | 2 Years 6 Months | Current |
Peer comparison
Gromaxformulations Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anglo-Indian Pharmaceuticals Private Limited | ₹1.12 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Medicotrans Private Limited | ₹1.12 Cr (FY 2024) | -28.0% | Pune, Maharashtra, India | |||
| Eramedica Private Limited | ₹1.12 Cr (FY 2025) | 64.0% | Jaipur, Rajasthan, India | |||
| Gromaxformulations Private Limitedthis company | ₹1.12 Cr (FY 2025) | -₹8.55 Lakh | -7.6% | -31.0% | Sriperumbudur, Tamil Nadu, India | |
| Hermes Animal Health Care Private Limited | ₹1.12 Cr (FY 2024) | -86.0% | Coimbatore, Tamil Nadu, India | |||
| Uro Medics Private Limited | ₹1.12 Cr (FY 2024) | -22.0% | Ernakulam, Kerala, India | |||
| Tricent Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2024) | 7056835.0% | Lucknow, Uttar Pradesh, India | |||
| Nuevo Therapeutics Private Limited | ₹1.11 Cr (FY 2025) | 6.0% | Hyderabad, Telangana, India | |||
| Shivaste Traders Private Limited | ₹1.11 Cr (FY 2024) | 5.0% | Greater Noida West, Uttar Pradesh, India |
To see the full peer comparison of Gromaxformulations Private Limited, buy the company report.
Auditor
Gromaxformulations Private Limited is audited by T S S K & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T S S K & ASSOCIATES | FY 2020 | 014063S |
Shareholding
The shareholding of Gromaxformulations Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Gromaxformulations Private Limited, buy the company report.
Charges & borrowings
Open charges
₹54.55 Lakh
Satisfied charges
₹16 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 May 2025 | 101110117 | Others | ₹4.95 Lakh | Open | |
| 21 Apr 2023 | 100709947 | Uco Bank | ₹6.6 Lakh | Open | |
| 20 Jun 2022 | 100594162 | Uco Bank | ₹3 Lakh | Open | |
| 20 Jun 2022 | 100594165 | Uco Bank | ₹40 Lakh | Open | |
| 07 Dec 2021 | 100540119 | City Union Bank Limited | ₹3 Lakh | Satisfied |
To see the full charge records of Gromaxformulations Private Limited, buy the company report.
Total charge records: 6 View all charges
Legal cases
No court or tribunal cases involving Gromaxformulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gromaxformulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gromaxformulations has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAHCG8924F1ZL | Tamil Nadu | Active | 09 Jul 2019 |
To see the full GST registrations and return filing status of Gromaxformulations Private Limited, buy the company report.
Recent activity
Gromaxformulations Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Karthick ceased to be Director on 24 Apr 2024.
AGM
Gromaxformulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 4.95 Lakh with Charge ID 101110117 was registered on 30 May 2025.
Filing
Gromaxformulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Ceased
Karthick ceased to be Director.
Appointed
Perumal Premila was appointed as Additional Director.
Ceased
Narasimham Tharakaram ceased to be Director.
Charges
A charge with Uco Bank amounted to Rs. 6.60 Lakh with Charge ID 100709947 was registered on 21 Apr 2023.
Charges
A charge registered on 07 Dec 2021 via Charge ID 100540119 with City Union Bank Limited was fully satisfied on 14 Jul 2022.
Charges
A charge registered on 21 Aug 2020 via Charge ID 100374334 with City Union Bank Limited was fully satisfied on 14 Jul 2022.
Charges
A charge with Uco Bank amounted to Rs. 3.00 Lakh with Charge ID 100594162 was registered on 20 Jun 2022.
Charges
A charge with Uco Bank amounted to Rs. 40.00 Lakh with Charge ID 100594165 was registered on 20 Jun 2022.
Charges
A charge with City Union Bank Limited amounted to Rs. 3.00 Lakh with Charge ID 100540119 was registered on 07 Dec 2021.
4 earlier events are in the company report.
Frequently asked questions
Gromaxformulations is an active private limited company based in Sriperumbudur, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 July 2019 (7+ years old) and is registered under CIN U24304TN2019PTC130323.
Gromaxformulations has 2 current directors:
- Murali Gurunathan - Director
- Perumal Premila - Additional Director
The latest financial statements of Gromaxformulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Gromaxformulations is 33AAHCG8924F1ZL, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Gromaxformulations is U24304TN2019PTC130323. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gromaxformulations was incorporated on 04 July 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Gromaxformulations by revenue are Anglo-Indian Pharmaceuticals Private Limited, Medicotrans Private Limited, Eramedica Private Limited, Hermes Animal Health Care Private Limited, Uro Medics Private Limited and 3 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Karthick ceased to be Director on 24 Apr 2024. Perumal Premila was appointed as Additional Director on 24 Apr 2024. Narasimham Tharakaram ceased to be Director on 20 Apr 2024. Gromaxformulations has 4 board changes on record in total.
Yes, Gromaxformulations is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0066240).
The registered office of Gromaxformulations is at Plot No. 6 – 1 Cholan Street, Jayalakshami Nagar Madananthapuram, Sriperumbudur, Tamil Nadu, India – 600125.
Gromaxformulations operates in the pharma industry, in the pharmaceutical retailers and distributors segment.